Amid a devastating resurgence of the coronavirus in parts of Brazil, federal health officials have finally voted to authorize two vaccines for emergency use. Sunday, Brazilian regulatory agency Anvisa approved both the Oxford/AstraZeneca vaccine and the Coronavac vaccine.